Lemborexant
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Lemborexant is used to treat sleep initiation and maintenance disorders, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 7, 2020. In 2024, Medicare Part D spent $21 million on Lemborexant across 58,000 claims for 15,000 beneficiaries.
Lemborexant is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $11.57 to $11.58 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$11.57 – $11.58
per EA
7d Activity
avg -0.1% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Eisai Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Orexin Receptor Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing LEMBOREXANT
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DAYVIGO 5 MG TABLET | $11.5776 per EA | -0.02% |
DAYVIGO 10 MG TABLET | $11.5670 per EA | -0.11% |
Frequently Asked Questions
What is Lemborexant used to treat?
Lemborexant is used to treat sleep initiation and maintenance disorders, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Lemborexant?
In 2024, Medicare Part D spent $21 million on Lemborexant across 58,000 claims for 15,000 beneficiaries.
How many Lemborexant products are on the market?
The Lemborexant drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Lemborexant?
NADAC reference prices for Lemborexant range from $11.5670 to $11.5776 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Lemborexant?
1 manufacturer lists Lemborexant in NADAC. Ranked by number of NDCs, the largest are Eisai Inc. (2).
How has the price of Lemborexant changed recently?
Over the past 7 days, 0 Lemborexant NDCs rose and 2 fell, with a market-wide average change of -0.1%.